Busca ao vivo
O TopFind está buscando as correspondências mais recentes para a sua pesquisa.
Analisamos 10000 resultados ao vivo para herzuma infusion and pharmacy services e reduzimos para 3 opções que parecem valer mais a comparação primeiro.
Os temas mais fortes nesta lista curta são Oncology e Oncology Services.
Fonte: National Cancer Centre Singapore (NCCS)
Descrição
Specialized administration of Herzuma (trastuzumab) within a dedicated oncology pharmacy and infusion setting. The service includes professional medical monitoring for patients with HER2-positive malignancies.
Melhor para
Oncology patients in Singapore, Specialized chemotherapy administration e HER2 Positive cancer management
Avaliação
Fonte: Celltrion Healthcare
Descrição
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Melhor para
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy e Oncology infusion treatment
Avaliação
Fonte: Celltrion Healthcare Singapore Private Limited
Descrição
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
Melhor para
HER2 Positive cancer care, Breast cancer patients e Affordable trastuzumab access
Avaliação
| Comparar | Herzuma Infusion and Pharmacy Services | Herzuma (Trastuzumab) | Herzuma |
|---|---|---|---|
| Fonte | National Cancer Centre Singapore (NCCS) | Celltrion Healthcare | Celltrion Healthcare Singapore Private Limited |
| Descrição | Specialized administration of Herzuma (trastuzumab) within a dedicated oncology pharmacy and infusion setting. The service includes professional medical monitoring for patients with HER2-positive malignancies. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. |
| Melhor para | Oncology patients in Singapore, Specialized chemotherapy administration e HER2 Positive cancer management | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy e Oncology infusion treatment | HER2 Positive cancer care, Breast cancer patients e Affordable trastuzumab access |
| Ação | |||
| Avaliação |
Se você quer começar pela opção mais equilibrada, eu recomendo:
"Herzuma Infusion and Pharmacy Services de National Cancer Centre Singapore (NCCS)."
Eu escolhi isso porque As a primary public healthcare institution, NCCS offers standardized administration of Herzuma with specialized oncology support staff.